| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Jun 24 | AKTX Akari Therapeutics | Stock Option Ordinary Shares, par value $0.0001 per share | Grant | Acquire A | No | No | 0.0014 | 5,000,000 | 7.00 k | 5,000,000 |
| 20 Jun 24 | APRE Aprea Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 1,045 | 0.00 | 1,844 |
| 20 Jun 24 | APRE Aprea Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 4.07 | 4,185 | 17.03 k | 4,185 |
| 23 Aug 23 | APRE Aprea Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 500 | 0.00 | 799 |
| 23 Aug 23 | APRE Aprea Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 3.65 | 2,000 | 7.30 k | 2,000 |
